These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 11002275)

  • 1. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
    Ermer J; Vogel M
    Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
    Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
    J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
    Wu Y
    Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On-line H/D exchange LC-MS strategy for structural elucidation of pharmaceutical impurities.
    Liu DQ; Wu L; Sun M; MacGregor PA
    J Pharm Biomed Anal; 2007 Jun; 44(2):320-9. PubMed ID: 17317074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
    Li M; Lin M; Rustum A
    J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chiral liquid chromatography-tandem mass spectrometric methods for stereoisomeric pharmaceutical determinations.
    Chen J; Korfmacher WA; Hsieh Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jun; 820(1):1-8. PubMed ID: 15866486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
    Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
    J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pharmaceutical impurities in formulated dosage forms.
    Pan C; Liu F; Motto M
    J Pharm Sci; 2011 Apr; 100(4):1228-59. PubMed ID: 24081463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LC/MS applications in drug development.
    Lee MS; Kerns EH
    Mass Spectrom Rev; 1999; 18(3-4):187-279. PubMed ID: 10568041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capillary electrophoresis-mass spectrometry in impurity profiling of pharmaceutical products.
    Visky D; Jimidar I; Van Ael W; Vennekens T; Redlich D; De Smet M
    Electrophoresis; 2005 Apr; 26(7-8):1541-9. PubMed ID: 15776482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hyphenated LC-MS/MS technique for characterization of impurity profile of quetiapine during drug development.
    Stolarczyk EU; Kutner A
    Acta Pol Pharm; 2010; 67(6):599-608. PubMed ID: 21229874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced monitoring of biopharmaceutical product purity using liquid chromatography-mass spectrometry.
    Laursen K; Justesen U; Rasmussen MA
    J Chromatogr A; 2011 Jul; 1218(28):4340-8. PubMed ID: 21621780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of gas chromatography/atmospheric pressure chemical ionisation time-of-flight mass spectrometry to impurity identification in Pharmaceutical Development.
    Bristow T; Harrison M; Sims M
    Rapid Commun Mass Spectrom; 2010 Jun; 24(11):1673-81. PubMed ID: 20486265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent studies on the electrospray ionisation mass spectrometric behaviour of selected nitrogen-containing drug molecules and its application to drug analysis using liquid chromatography-electrospray ionisation mass spectrometry.
    Smyth WF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 824(1-2):1-20. PubMed ID: 16095984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS characterization of trace impurities contained in calcium folinate.
    Francese G; Corana F; Meneghetti O; Marazza F
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
    Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
    J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput quantitative bioanalysis by LC/MS/MS.
    Jemal M
    Biomed Chromatogr; 2000 Oct; 14(6):422-9. PubMed ID: 11002279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
    Mück W
    Pharmazie; 1999 Sep; 54(9):639-44. PubMed ID: 10522267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of unknown compounds in azithromycin bulk samples with liquid chromatography coupled to ion trap mass spectrometry.
    Debremaeker D; Visky D; Chepkwony HK; Van Schepdael A; Roets E; Hoogmartens J
    Rapid Commun Mass Spectrom; 2003; 17(4):342-50. PubMed ID: 12569445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.